Join the club for FREE to access the whole archive and other member benefits.

Haydar Frangoul

Pediatric hematologist-oncologist

Since 2015, Dr. Frangoul has served as the Medical Director of Pediatric Hematology/Oncology for the Sarah Cannon Center for Blood Cancer at The Children's Hospital at TriStar Centennial. He also serves as an investigator for Sarah Cannon Research Institute, focusing on the research and treatment of blood disorders for pediatric and adult patients, with a specialization in blood and marrow transplantation.

Dr. Frangoul is internationally recognized for his research and expertise in stem cell transplantation, having published more than 120 peer reviewed manuscripts and presented on more than 35 abstracts. Prior to joining Sarah Cannon and TriStar Health, Dr. Frangoul was the Director of the Pediatric Stem Cell Transplant program at Vanderbilt University from 1999-2014.

Visit website: https://tristarchildrensspecialists.com/physicians/profile/Haydar-Adib-Frangoul-MD

 haydar-frangoul-9aa881a4

 hfrangoul

See also: Health Organisation TriStar Health - Largest healthcare provider in Middle Tennessee and Southern Kentucky

Details last updated 28-Nov-2019

Haydar Frangoul News

CRISPR's gene editing therapy finds cure for blood cancer

CRISPR's gene editing therapy finds cure for blood cancer

STAT - 05-Dec-2020

Early data from Vertex & CRISPR showed promising results to cure blood disorders

CRISPR gene editing to cure beta thalassaemia and sickle cell disease

CRISPR gene editing to cure beta thalassaemia and sickle cell disease

New Scientist - 12-Jun-2020

Didn't change the inherited faulty gene, but gene to switch on fetal haemoglobin production

First attempt to use CRISPR tool to treat a genetic disorder

First attempt to use CRISPR tool to treat a genetic disorder

NPR - 29-Jul-2019

Cells are being taken from patients' bone marrow and genetically modified with CRISPR